BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1709389)

  • 1. Development and mechanisms of interferon resistance.
    Kloke O; Niederle N
    Cancer Treat Rev; 1990 Dec; 17 Suppl A():81-8. PubMed ID: 1709389
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and biological activity of the interferons in hematologic malignancies.
    Gutterman JU
    Prog Clin Biol Res; 1989; 288():337-48. PubMed ID: 2470111
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological molecules in the treatment of hematological disorders.
    Kurzrock R; Talpaz M; Gutterman U
    Sangre (Barc); 1989 Feb; 34(1):53-8. PubMed ID: 2469130
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia.
    Baer MR; Ozer H; Foon KA
    Br J Haematol; 1992 Jun; 81(2):167-9. PubMed ID: 1643013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferons in the treatment of hematological diseases].
    Jantunen E; Nousiainen T
    Duodecim; 1998; 114(12):1240-7. PubMed ID: 11524770
    [No Abstract]   [Full Text] [Related]  

  • 6. The current status of interferon alpha in haemic malignancy.
    Galvani DW; Cawley JC
    Blood Rev; 1990 Sep; 4(3):175-80. PubMed ID: 2245253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon-alpha in therapy of malignant hemoblastoses].
    Schuler M; Aulitzky WE; Schneller F; Peschel C; Huber C
    Internist (Berl); 1995 Dec; 36(12):1133-8. PubMed ID: 8567218
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interferon and its use for treating hairy cell leukemia].
    Markov V
    Vutr Boles; 1990; 29(3):34-40. PubMed ID: 1704666
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotherapy with interferon--1988.
    Figlin RA
    Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of interferon in patients with hairy cell leukemia and myeloproliferative disorders].
    Skotnicki AB; Wolska-Smoleń T
    Acta Haematol Pol; 1994; 25(2 Suppl 1):124-35. PubMed ID: 8067197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotherapy of chronic myelogenous leukemia with interferon.
    Ozer H
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):14-20. PubMed ID: 2461592
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy of chronic myelogenous leukemia with interferon.
    Kurzrock R; Gutterman JU; Kantarjian H; Talpaz M
    Cancer Invest; 1989; 7(1):83-91. PubMed ID: 2472193
    [No Abstract]   [Full Text] [Related]  

  • 13. Action of interferon-alpha on hairy cell leukemia: expression of specific receptors and (2'-5')oligo (A) synthetase in tumor cells from sensitive and resistant patients.
    Billard C; Ferbus D; Sigaux F; Castaigne S; Degos L; Flandrin G; Falcoff E
    Leuk Res; 1988; 12(1):11-8. PubMed ID: 2965776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon therapy for lymphoproliferative disorders.
    Roth MS; Bunn PA; Foon KA
    Cancer Treat Res; 1988; 38():231-52. PubMed ID: 2484433
    [No Abstract]   [Full Text] [Related]  

  • 15. The biology of hairy cell leukemia. A study of the practical aspects of interferon-treatment, its mechanism of action and on the pathogenesis of anemia.
    Nielsen B
    APMIS Suppl; 1995; 52():1-39. PubMed ID: 7576791
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon therapy of hematologic malignancies.
    Foon KA
    Cancer Treat Res; 1998; 94():1-21. PubMed ID: 9587679
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interferon in the treatment of Philadelphia-positive chronic myeloid leukemia].
    Morra E; Alimena G; Lazzarino M; Liberati AM; Montefusco E; Inverardi D; Bernasconi P; Mancini M; Donti E; Senatore M
    Haematologica; 1990; 75 Suppl 4():33-40. PubMed ID: 1705912
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity of different types of interferons in the treatment of hairy-cell leukemia.
    von Wussow P; Freund M; Dahle S; Jakschies D; Poliwode H; Deicher H
    N Engl J Med; 1988 Nov; 319(18):1226-7. PubMed ID: 2459619
    [No Abstract]   [Full Text] [Related]  

  • 19. alpha-Interferon in hematological malignancies.
    Giles FJ; Ozer H
    Curr Opin Biotechnol; 1991 Dec; 2(6):847-50. PubMed ID: 1367959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferons for the treatment of hematological malignancies.
    Urabe A
    Oncology; 1994; 51(2):137-41. PubMed ID: 7515169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.